Biologic Drugs

Sep 15, 2017
By Pharmaceutical Technology Editors
The approval marks the first biosimilar approved in the United States for treating cancers.
Sep 12, 2017
By Pharmaceutical Technology Editors
The company has extended its presence in the US market to support its growing business in the region.
Sep 07, 2017
By Pharmaceutical Technology Editors
Merck KGaA completes the divestment of its biosimilars business as part of its strategy to focus on developing a pipeline of innovator drugs.
Sep 06, 2017
By Pharmaceutical Technology Editors
Pfizer’s Mylotarg, an anti-body drug conjugate once voluntarily withdrawn, returns to the market under a new dosing regimen for treating leukemia.
Sep 02, 2017
Pharmaceutical Technology
Innovation speeds discovery, drives down costs, and improves productivity.
Sep 02, 2017
Pharmaceutical Technology
Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.
Sep 02, 2017
Pharmaceutical Technology
FDA works with industry on strategies for assuring high-quality regenerative medicines.
Aug 30, 2017
By Pharmaceutical Technology Editors
FDA approves Novartis’ CAR-T therapy, marking the first time a cell therapy based on gene transfer has been approved in the United States for any indication.
Aug 29, 2017
By Pharmaceutical Technology Editors
AstraZeneca and Takeda will partner to develop and commercialize MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD).
Aug 29, 2017
By Pharmaceutical Technology Editors
Gilead will gain a robust pipeline of cell therapy products, with one lead candidate, a CAR T therapy, anticipated to gain FDA approval in the fourth quarter.
native1_300x100
lorem ipsum